Medicaid Patients Undergo Total Joint Arthroplasty at Lower-Volume Hospitals by Lower-Volume Surgeons and Have Poorer

Anna Cohen-Rosenblum1, Mary K Richardson2, Kevin C Liu2

  • 1Department of Orthopaedic Surgery, Louisiana State University, New Orleans, Louisiana.

Abstract

Insights

Medicaid patients undergoing total joint arthroplasty (TJA) are more likely to be treated by lower-volume surgeons and hospitals, leading to increased risks of complications like deep vein thrombosis, pulmonary embolism, infection, and readmission.

Area of Science:

  • Orthopedic Surgery
  • Health Services Research
  • Public Health

Background:

  • Medicaid coverage is linked to poorer outcomes after total hip arthroplasty (THA) and total knee arthroplasty (TKA).
  • Lower surgeon and hospital volume in total joint arthroplasty (TJA) is also associated with adverse outcomes.

Purpose of the Study:

  • To investigate the relationship between Medicaid insurance status, surgeon case volume, and hospital case volume.
  • To evaluate postoperative complication rates in TJA patients based on insurance type and provider volume.

Main Methods:

  • Analysis of the Premier Healthcare Database for adult primary TJA patients (2016-2019).
  • Stratification of patients by insurance status (Medicaid vs. non-Medicaid).
  • Multivariable analyses adjusting for demographics, comorbidities, and provider volume to assess 90-day complication risks.

Main Results:

  • 4.5% of 986,230 TJA patients had Medicaid.
  • Medicaid patients were more frequently treated by low-volume surgeons (≤100 cases/year) and at low-volume hospitals (≤500 cases/year).
  • Medicaid patients faced higher adjusted risks for deep vein thrombosis, pulmonary embolism, periprosthetic joint infection, and 90-day readmission.

Conclusions:

  • Medicaid patients undergoing TJA are disproportionately treated by lower-volume providers, correlating with increased postoperative complications.
  • Further research is needed to explore socioeconomic factors, insurance, and outcomes in this patient group.